Companies: 10,795·Total market cap: $144.5T
Filament Health Corp.

Filament Health Corp.

FLHLFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$26179
P/E Ratio
52W High$0.0201
52W Low$0.0001

Filament Health Corp. (FLHLF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

flhlf · pe ratio · data through Dec 31, 2024

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Filament Health Corp. (FLHLF) measures how much investors pay for each dollar of the company's trailing earnings. FLHLF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31

Forward P/E
N/A
Based on 0 analysts
EPS (TTM)
-$0.01
TTM · diluted EPS
PEG Ratio
-0.04
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Filament Health Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2024 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Filament Health Corp.
Filament Health Corp.You
FLHLF
$0MN/A-$0.01
Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc.
ACUR
$0MN/A-$0.02
Amazonas Florestal, Ltd
Amazonas Florestal, Ltd
AZFL
$0M16.39x+98.7%$0.00
Curative Biosciences, Inc.
Curative Biosciences, Inc.
CBDX
$0MN/A-$0.00
Cannonau Corp.
Cannonau Corp.
CNNC
$0M0.11x-98.7%$0.14
GeneLink, Inc.
GeneLink, Inc.
GNLKQ
$0MN/A-$0.01
Kali, Inc.
Kali, Inc.
KALY
$0MN/A-$0.00
Industry Average
2 peers with valid PE
8.25xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2024-12-31Latest
FY2024
$-0.02
2023-12-31
FY2023
$-0.03
2022-12-31
FY2022
$-0.10
2021-12-31
FY2021
$-0.06
2020-12-31
FY2020
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Filament Health Corp. (FLHLF) measures how much investors pay for each dollar of the company's trailing earnings. FLHLF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.01 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FLHLF pe ratio · 6 questions

FLHLF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via FLHLF's SEC 10-K and 10-Q filings.

FLHLF PE ratioWhat is FLHLF PE ratioCurrent PE ratio of FLHLFFLHLF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Filament Health Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09